ALBAWABA – Omalizumab was originally approved in 2003 for the treatment of moderate to severe persistent allergic asthma, however it recently received an approval from the Food and Drug Administration (FDA) to Limit Allergic Reactions to Several Foods Following Unintentional Exposure, with a new study published on Sunday showing the efficacy of the drug. The study, published in the New England Journal of Medicine, tested treatment with Omalizumab on 177 ...